Inventor
VARNEY MICHAEL D
US26 patents
⚠️ This page may combine multiple inventors who share the name “VARNEY MICHAEL D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AGOURON PHARMA
25 patentsUS5707992AJan 13, 1998
Antiproliferative quinazolines
AGOURON PHARMA44 citations95
US5608082AMar 4, 1997
Compounds useful as antiproliferative agents and GARFT inhibitors
AGOURON PHARMA27 citations92
US5885996AMar 23, 1999
Antiproliferative quinazolines
AGOURON PHARMA36 citations90
US5646141AJul 8, 1997
Compounds useful as antiproliferative agents and GARFT inhibitors
AGOURON PHARMA17 citations81
US5739141AApr 14, 1998
Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds
AGOURON PHARMA9 citations73
US5726312AMar 10, 1998
Methods for preparing antiproliferative 5-substituted pyrimidone compounds
AGOURON PHARMA7 citations73
US5641774AJun 24, 1997
Compounds useful as antiproliferative agents and garft inhibitors
AGOURON PHARMA6 citations73
US5639749AJun 17, 1997
Compounds useful as antiproliferative agents and garft inhibitors
AGOURON PHARMA3 citations73
US5625061AApr 29, 1997
Compounds useful in preparing antiproliferative agents and garft inhibitors
AGOURON PHARMA3 citations73
US5594139AJan 14, 1997
Processes for preparing antiproliferative garft-inhibiting compounds
AGOURON PHARMA7 citations73
US6525050B1Feb 25, 2003
(4-oxo-2-pyrimidinyl)thioalkyl compounds useful as AICARFT inhibitors
AGOURON PHARMA11 citations69
US6207670B1Mar 27, 2001
Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds
AGOURON PHARMA1 citations62
US5981748ANov 9, 1999
Synthesis of optically pure compounds useful as GARFT inhibitors and their intermediates
AGOURON PHARMA2 citations62
US5945427AAug 31, 1999
Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds
AGOURON PHARMA3 citations62
US5831100ANov 3, 1998
Syntheses of optically pure compounds useful as GARFT inhibitors and their intermediates
AGOURON PHARMA1 citations62
US5641771AJun 24, 1997
Compounds useful as antiproliferative agents and garft inhibitors
AGOURON PHARMA1 citations62
US5639747AJun 17, 1997
Compounds useful as antiproliferative agents and garft inhibitors
AGOURON PHARMA1 citations62
US5610319AMar 11, 1997
Compound useful as antiproliferative agents and GARFT inhibitors
AGOURON PHARMA1 citations62
US6001851ADec 14, 1999
HIV protease inhibitors
AGOURON PHARMA4 citations60
US5574039ANov 12, 1996
Antiproliferative compounds having nitrogen-containing tricyclic ring systems and phenyl substituents
AGOURON PHARMA3 citations59
US6953858B2Oct 11, 2005
HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
AGOURON PHARMA4 citations57
US5498727AMar 12, 1996
Preparation of benzindole compounds from naphthalene compounds
AGOURON PHARMA3 citations55
US6323210B2Nov 27, 2001
Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds
AGOURON PHARMA0 citations51
US7179918B2Feb 20, 2007
HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
AGOURON PHARMA0 citations47
US5545744AAug 13, 1996
Cyano naphthalene compounds
AGOURON PHARMA1 citations45